These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26601840)

  • 1. Methylarginines in Mice with Experimental Atherosclerosis.
    Gilinsky MA; Sukhovershin RA; Cherkanova MS
    Bull Exp Biol Med; 2015 Nov; 160(1):13-6. PubMed ID: 26601840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated arginine analogues: their potential role in atherosclerosis and cognition using the poloxamer-407-induced mouse model of dyslipidemia.
    Gilinsky MA; Johnston TP; Zhukova NA; Dubrovina NI; Latysheva TV; Naumenko SE; Sukhovershin RA
    Can J Physiol Pharmacol; 2016 Nov; 94(11):1122-1131. PubMed ID: 27454106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox.
    Tsikas D; Böger RH; Sandmann J; Bode-Böger SM; Frölich JC
    FEBS Lett; 2000 Jul; 478(1-2):1-3. PubMed ID: 10922458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asymmetric dimethylarginine: predictor of cardiovascular diseases?].
    Németh B; Kustán P; Németh Á; Lenkey Z; Cziráki A; Kiss I; Sulyok E; Ajtay Z
    Orv Hetil; 2016 Mar; 157(13):483-7. PubMed ID: 26996894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
    Vallance P; Leiper J
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1023-30. PubMed ID: 15105281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of L-[guanidino-(15)N(2)]-arginine to (15)N-labeled nitrate by gas chromatography--mass spectrometry.
    Böger RH; Tsikas D; Bode-Böger SM; Phivthong-Ngam L; Schwedhelm E; Frölich JC
    Nitric Oxide; 2004 Aug; 11(1):1-8. PubMed ID: 15350551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH; Bode-Böger SM
    Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of regulation of endogenous methylarginine concentrations in clinical practice].
    Kopieczna-Grzebieniak E; Goss M
    Przegl Lek; 2005; 62(12):1494-501. PubMed ID: 16786781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
    Caplin B; Leiper J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1343-53. PubMed ID: 22460557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of free methylarginines in rat tissues and in the bovine brain.
    Ueno S; Sano A; Kotani K; Kondoh K; Kakimoto Y
    J Neurochem; 1992 Dec; 59(6):2012-6. PubMed ID: 1431891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of free methylarginines via the proteasome and autophagy pathways in cultured cells.
    Shirakawa T; Kako K; Shimada T; Nagashima Y; Nakamura A; Ishida J; Fukamizu A
    Mol Med Rep; 2011; 4(4):615-20. PubMed ID: 21584492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-stage atherosclerosis in poloxamer 407-induced hyperlipidemic mice: pathological features and changes in the lipid composition of serum lipoprotein fractions and subfractions.
    Korolenko TA; Johnston TP; Tuzikov FV; Tuzikova NA; Pupyshev AB; Spiridonov VK; Goncharova NV; Maiborodin IV; Zhukova NA
    Lipids Health Dis; 2016 Jan; 15():16. PubMed ID: 26801626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of asymmetric dimethylarginine (ADMA) or monomethylarginine (L-NMMA) to block endothelium-dependent, nitric oxide-mediated relaxation in rat aorta is inversely related to the efficacy of the relaxant stimulus.
    Al-Zobaidy MJ; Martin W
    Eur J Pharmacol; 2014 Oct; 741():171-7. PubMed ID: 25149663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study.
    Chirinos JA; David R; Bralley JA; Zea-Díaz H; Muñoz-Atahualpa E; Corrales-Medina F; Cuba-Bustinza C; Chirinos-Pacheco J; Medina-Lezama J
    Hypertension; 2008 Dec; 52(6):1051-9. PubMed ID: 18852383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of endogenous nitric oxide synthase inhibitors on endothelial SK3 expression.
    Zhou Z; Jiang DJ; Jia SJ; Xiao HB; Xiao B; Li YJ
    Vascul Pharmacol; 2007; 47(5-6):265-71. PubMed ID: 17869187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia.
    Lücke T; Tsikas D; Kanzelmeyer N; Vaske B; Das AM
    Metabolism; 2006 Dec; 55(12):1599-603. PubMed ID: 17142130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats.
    Fu YF; Xiong Y; Guo Z
    Eur J Pharmacol; 2005 Jan; 508(1-3):167-75. PubMed ID: 15680268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.